TGFβ3 and loading increases osteocyte survival in human cancellous bone cultured ex vivo

Cell Biochemistry and Function

Volumn 27, Issue 1, 2009, Pages 23-29

  Simpson, Angharad E ^a   Stoddart, Martin J ^a   Davies, Catrin M ^a   Jähn, Katharina ^a   Furlong, Pamela I ^a   Gasser, Jürg A ^b   Jones, David B ^c   Noble, Brendon S ^d   Richards, Robert G ^a  

^a AO RESEARCH INSTITUTE   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c PHILIPPS UNIVERSITY MARBURG   (Germany)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Bioreactor; Culture; Human bone; TGF beta; Viability

Indexed keywords

LACTATE DEHYDROGENASE; TRANSFORMING GROWTH FACTOR BETA3; TGFB3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; BIOMECHANICS; BIOREACTOR; BONE STRUCTURE; CANCELLOUS BONE; CELL CULTURE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; EX VIVO STUDY; EXPLANT; HUMAN; HUMAN CELL; MECHANICAL STRESS; OSTEOCYTE; PRIORITY JOURNAL; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; FEMUR HEAD; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; TIME; TISSUE CULTURE TECHNIQUE; WEIGHT BEARING;

BIOREACTORS; CELL SURVIVAL; FEMUR HEAD; HUMANS; L-LACTATE DEHYDROGENASE; OSTEOCYTES; STRESS, PHYSIOLOGICAL; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TRANSFORMING GROWTH FACTOR BETA3; WEIGHT-BEARING;

EID: 60649121985     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1529     Document Type: Article

References (24)

1. Bonewald L. Transforming growth factor-β. In Principles of Bone Biology, Vol 2, Bilezikian J, Raisz L, Rodan GA (eds). Academic Press: London, 1996; 903-919, Chapter 49.
2. Bonewald LF, Mundy GR. Role of transforming growth factor-beta in bone remodeling. Clin Orthop Relat Res 1990; 250: 261-276.
3. Davies CM, Jones DB, Stoddart MJ, et al. Mechanically loaded ex vivo bone culture system 'Zetos': systems and culture preparation. Eur Cell Mater 2006; 11: 57-75.
4. Dufour C, Holy X, Marie PJ. Transforming growth factor-beta prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling. Am J Physiol Endocrinol Metab 2008; 294: E794-E801.
5. Freshney RI. Culture of Animal Cells. Wiley-Liss: New York, 1994: 396-399.
6. Heino TJ, Hentunen TA, Vaananen HK. Osteocytes inhibit osteoclastic bone resorption through transforming growth factor-beta: enhancement by estrogen. J Cell Biochem 2002; 85: 185-197.
7. Hock JM, Canalis E, Centrella M. Transforming growth factor-beta stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology 1990; 126: 421-426.
8. Jones DB, Broeckmann E, Pohl T, Smith EL. Development of a mechanical testing and loading system for trabecular bone studies for long term culture. Eur Cell Mater 2003; 5: 48-59.
9. Karsdal MA, Andersen TA, Bonewald L, Christiansen C. Matrix metalloproteinases (MMPs) safeguard osteoblasts from apoptosis during transdifferentiation into osteocytes: MT1-MMP maintains osteocyte viability. DNA Cell Biol 2004; 23: 155-165.
10. Mackie EJ, Trechsel U. Stimulation of bone formation in vivo by transforming growth factor-beta: remodeling of woven bone and lack of inhibition by indomethacin. Bone 1990; 11: 295-300.
11. Mann V, Huber C, Kogianni G, Jones D, Noble B. The influence of mechanical stimulation on osteocyte apoptosis and bone viability in human trabecular bone. J Musculoskelet Neuronal Interact 2006; 6: 408-417.
12. Mullender MG, van der Meer DD, Huiskes R, Lips P. Osteocyte density changes in aging and osteoporosis. Bone 1996; 18: 109-113.
13. Noda M, Camilliere JJ. In vivo stimulation of bone formation by transforming growth factor-beta. Endocrinology 1989; 124: 2991-2994.
14. Noda M, Rodan GA. Type-beta transforming growth factor inhibits proliferation and expression of alkaline phosphatase in murine osteoblast-like cells. Biochem Biophys Res Commun 1986; 140: 56-65.
15. Odgaard A, Hvid I, Linde F. Compressive axial strain distributions in cancellous bone specimens. J Biomech 1989; 22: 829-835.
16. Oreffo RO, Bonewald L, Kukita A, et al. Inhibitory effects of the bone-derived growth factors osteoinductive factor and transforming growth factor-beta on isolated osteoclasts. Endocrinology 1990; 126: 3069-3075.
17. Pearce AI, Richards RG, Milz S, Schneider E, Pearce SG. Animal models for implant biomaterial research in bone: a review. Eur Cell Mater 2007; 13: 1-10.
18. Pfeilschifter J, D'Souza SM, Mundy GR. Effects of transforming growth factor-beta on osteoblastic osteosarcoma cells. Endocrinology 1987; 121: 212-218.
19. Qiu S, Rao DS, Palnitkar S, Parfitt AM. Relationships between osteocyte density and bone formation rate in human cancellous bone. Bone 2002; 31: 709-711.
20. Qiu S, Rao DS, Palnitkar S, Parfitt AM. Reduced iliac cancellous osteocyte density in patients with osteoporotic vertebral fracture. J Bone Miner Res 2003; 18: 1657-1663.
21. Rawlinson SC, Mosley JR, Suswillo RF, Pitsillides AA, Lanyon LE. Calvarial and limb bone cells in organ and monolayer culture do not show the same early responses to dynamic mechanical strain. J Bone Miner Res 1995; 10: 1225-1232.
22. Stoddart MJ, Furlong PI, Simpson A, Davies CM, Richards RG. A comparison of non-radioactive methods for assessing viability in ex vivo cultured cancellous bone: technical note. Eur Cell Mater 2006; 12: 16-25.
23. ten-Dijke P, Iwata KK, Goddard C, et al. Recombinant transforming growth factor type beta 3: biological activities and receptor-binding properties in isolated bone cells. Mol Cell Biol 1990; 10: 4473-4479.
24. Tomkinson A, Reeve J, Shaw RW, Noble BS. The death of osteocytes via apoptosis accompanies estrogen withdrawal in human bone. J Clin Endocrinol Metab 1997; 82: 3128-3135.